Diagnostics stocks hit a rough patch this week. Shares of Bionano Genomics (NASDAQ: BNGO) were down 13.5% for the week as of the market close on Thursday. Invitae (NYSE: NVTA) stock was off by 12% over the last four days, while Opko Health (NASDAQ: OPK) shares have tumbled by 11.7%.